SkinBioTherapeutics plc (AIM:SBTX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
15.75
-0.10 (-0.63%)
Dec 31, 2025, 11:21 AM GMT+1

SkinBioTherapeutics Ratios and Metrics

Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
4143182232100
Upgrade
Market Cap Growth
-6.09%144.31%-17.78%-31.83%-68.11%353.88%
Upgrade
Enterprise Value
374315212994
Upgrade
Last Close Price
0.160.170.090.130.200.64
Upgrade
PS Ratio
8.799.3714.72163.89424.66-
Upgrade
PB Ratio
4.334.625.9910.8512.8319.09
Upgrade
P/TBV Ratio
7.958.48-16.7217.1621.24
Upgrade
EV/Sales Ratio
7.979.3312.45158.92384.18-
Upgrade
Debt / Equity Ratio
0.110.110.280.050.050.03
Upgrade
Asset Turnover
0.540.540.310.050.02-
Upgrade
Inventory Turnover
2.802.802.080.60--
Upgrade
Quick Ratio
4.214.210.633.054.1911.91
Upgrade
Current Ratio
4.844.840.933.254.5812.50
Upgrade
Return on Equity (ROE)
-11.24%-11.24%-115.85%-126.85%-72.62%-37.31%
Upgrade
Return on Assets (ROA)
-8.10%-8.10%-46.50%-66.02%-42.26%-22.00%
Upgrade
Return on Capital (ROIC)
-9.89%-9.89%-61.71%-79.79%-46.84%-23.93%
Upgrade
Return on Capital Employed (ROCE)
-10.50%-10.50%-85.20%-145.30%-115.80%-28.10%
Upgrade
Earnings Yield
-1.71%-1.60%-16.16%-13.10%-8.80%-1.44%
Upgrade
FCF Yield
-3.05%-2.85%-15.40%-12.64%-8.42%-1.56%
Upgrade
Buyback Yield / Dilution
-22.32%-22.32%-13.10%-5.06%-6.87%-14.53%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.